Cargando…
ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15
BACKGROUND: It is known that the transcription factor zinc finger protein 703 (ZNF703) plays an important role in physiological functions and the occurrence and development of various tumors. However, the role and mechanism of ZNF703 in ovarian cancer are unclear. MATERIALS AND METHODS: Immunohistoc...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693506/ https://www.ncbi.nlm.nih.gov/pubmed/33246486 http://dx.doi.org/10.1186/s13046-020-01770-0 |
_version_ | 1783614760111046656 |
---|---|
author | Wang, Shuang Wang, Caixia Hu, Yuexin Li, Xiao Jin, Shan Liu, Ouxuan Gou, Rui Zhuang, Yuan Guo, Qian Nie, Xin Zhu, Liancheng Liu, Juanjuan Lin, Bei |
author_facet | Wang, Shuang Wang, Caixia Hu, Yuexin Li, Xiao Jin, Shan Liu, Ouxuan Gou, Rui Zhuang, Yuan Guo, Qian Nie, Xin Zhu, Liancheng Liu, Juanjuan Lin, Bei |
author_sort | Wang, Shuang |
collection | PubMed |
description | BACKGROUND: It is known that the transcription factor zinc finger protein 703 (ZNF703) plays an important role in physiological functions and the occurrence and development of various tumors. However, the role and mechanism of ZNF703 in ovarian cancer are unclear. MATERIALS AND METHODS: Immunohistochemistry was used to analyze the expression of ZNF703 in ovarian cancer patients and to assess the effect of ZNF703 expression on the survival and prognosis of ovarian cancer patients. ZNF703 overexpression and suppression expression experiments were used to evaluate the effect of ZNF703 on malignant biological behavior of ovarian cancer cells in vitro. Detecting the interaction between HE4 and ZNF703 by immunofluorescence colocalization and coprecipitation, and nuclear translocation. Chromatin immunoprecipitation-sequencing (ChIP-Seq), dual luciferase reporter assay, ChIP-PCR, in vivo model were applied to study the molecular mechanism of ZNF703 affecting the development of ovarian cancer. RESULTS: ZNF703 was highly expressed in ovarian cancer tissues, and its expression level is related to the prognosis of ovarian cancer patients. In vivo and in vitro experiments confirmed that ZNF703 overexpression/inhibition expression will promoted/inhibited the malignant biological behavior of ovarian cancer. Mechanically, ZNF703 interacted with HE4, and HE4 promoted nuclear translocation of ZNF703. ChIP-Seq identified multiple regulatory targets of ZNF703, of which ZNF703 directly binds to the enhancer region of PEA15 to promote the transcription of PEA15 and thereby promoted the proliferation of cancer cells. CONCLUSION: The results showed that ZNF703 as an oncogene played an important role in the epigenetic modification of ovarian cancer proliferation, and suggested that ZNF703 as a transcription factor may become a prognostic factor and a potential therapeutic target for ovarian cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-020-01770-0. |
format | Online Article Text |
id | pubmed-7693506 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-76935062020-11-30 ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15 Wang, Shuang Wang, Caixia Hu, Yuexin Li, Xiao Jin, Shan Liu, Ouxuan Gou, Rui Zhuang, Yuan Guo, Qian Nie, Xin Zhu, Liancheng Liu, Juanjuan Lin, Bei J Exp Clin Cancer Res Research BACKGROUND: It is known that the transcription factor zinc finger protein 703 (ZNF703) plays an important role in physiological functions and the occurrence and development of various tumors. However, the role and mechanism of ZNF703 in ovarian cancer are unclear. MATERIALS AND METHODS: Immunohistochemistry was used to analyze the expression of ZNF703 in ovarian cancer patients and to assess the effect of ZNF703 expression on the survival and prognosis of ovarian cancer patients. ZNF703 overexpression and suppression expression experiments were used to evaluate the effect of ZNF703 on malignant biological behavior of ovarian cancer cells in vitro. Detecting the interaction between HE4 and ZNF703 by immunofluorescence colocalization and coprecipitation, and nuclear translocation. Chromatin immunoprecipitation-sequencing (ChIP-Seq), dual luciferase reporter assay, ChIP-PCR, in vivo model were applied to study the molecular mechanism of ZNF703 affecting the development of ovarian cancer. RESULTS: ZNF703 was highly expressed in ovarian cancer tissues, and its expression level is related to the prognosis of ovarian cancer patients. In vivo and in vitro experiments confirmed that ZNF703 overexpression/inhibition expression will promoted/inhibited the malignant biological behavior of ovarian cancer. Mechanically, ZNF703 interacted with HE4, and HE4 promoted nuclear translocation of ZNF703. ChIP-Seq identified multiple regulatory targets of ZNF703, of which ZNF703 directly binds to the enhancer region of PEA15 to promote the transcription of PEA15 and thereby promoted the proliferation of cancer cells. CONCLUSION: The results showed that ZNF703 as an oncogene played an important role in the epigenetic modification of ovarian cancer proliferation, and suggested that ZNF703 as a transcription factor may become a prognostic factor and a potential therapeutic target for ovarian cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-020-01770-0. BioMed Central 2020-11-27 /pmc/articles/PMC7693506/ /pubmed/33246486 http://dx.doi.org/10.1186/s13046-020-01770-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wang, Shuang Wang, Caixia Hu, Yuexin Li, Xiao Jin, Shan Liu, Ouxuan Gou, Rui Zhuang, Yuan Guo, Qian Nie, Xin Zhu, Liancheng Liu, Juanjuan Lin, Bei ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15 |
title | ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15 |
title_full | ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15 |
title_fullStr | ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15 |
title_full_unstemmed | ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15 |
title_short | ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15 |
title_sort | znf703 promotes tumor progression in ovarian cancer by interacting with he4 and epigenetically regulating pea15 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693506/ https://www.ncbi.nlm.nih.gov/pubmed/33246486 http://dx.doi.org/10.1186/s13046-020-01770-0 |
work_keys_str_mv | AT wangshuang znf703promotestumorprogressioninovariancancerbyinteractingwithhe4andepigeneticallyregulatingpea15 AT wangcaixia znf703promotestumorprogressioninovariancancerbyinteractingwithhe4andepigeneticallyregulatingpea15 AT huyuexin znf703promotestumorprogressioninovariancancerbyinteractingwithhe4andepigeneticallyregulatingpea15 AT lixiao znf703promotestumorprogressioninovariancancerbyinteractingwithhe4andepigeneticallyregulatingpea15 AT jinshan znf703promotestumorprogressioninovariancancerbyinteractingwithhe4andepigeneticallyregulatingpea15 AT liuouxuan znf703promotestumorprogressioninovariancancerbyinteractingwithhe4andepigeneticallyregulatingpea15 AT gourui znf703promotestumorprogressioninovariancancerbyinteractingwithhe4andepigeneticallyregulatingpea15 AT zhuangyuan znf703promotestumorprogressioninovariancancerbyinteractingwithhe4andepigeneticallyregulatingpea15 AT guoqian znf703promotestumorprogressioninovariancancerbyinteractingwithhe4andepigeneticallyregulatingpea15 AT niexin znf703promotestumorprogressioninovariancancerbyinteractingwithhe4andepigeneticallyregulatingpea15 AT zhuliancheng znf703promotestumorprogressioninovariancancerbyinteractingwithhe4andepigeneticallyregulatingpea15 AT liujuanjuan znf703promotestumorprogressioninovariancancerbyinteractingwithhe4andepigeneticallyregulatingpea15 AT linbei znf703promotestumorprogressioninovariancancerbyinteractingwithhe4andepigeneticallyregulatingpea15 |